Opinion
Video
Drs. Shore & McKay discuss treatment selection for metastatic & castration-resistant prostate cancer, the current landscape, and key factors guiding personalized treatment decisions.
Study finds only half of patients undergoing 24-hour urine tests receive complete testing
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
Study finds inadequate patient education for scheduled urologic procedures
First European patient treated for urethral stricture with novel drug-coated balloon catheter
FDA approves lumasiran as first drug for primary hyperoxaluria type 1